glp 1 competitors approval Lilly is now pharma's top revenue company. It just got FDA for an oral GLP-1, but Wall Street isn't celebrating GLP-1 receptor agonists Metabolic Axis Competing in the Post-Patent GLP-1
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18






























